149 related articles for article (PubMed ID: 18677385)
1. [Clinicopathologic study of hepatosplenic T-cell lymphoma].
Zhang S; Nong L; Ren YL; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):387-91. PubMed ID: 18677385
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules.
Sadahira Y; Notohara K; Manabe T
J Clin Pathol; 2003 Aug; 56(8):631-3. PubMed ID: 12890821
[TBL] [Abstract][Full Text] [Related]
3. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
[TBL] [Abstract][Full Text] [Related]
4. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
[TBL] [Abstract][Full Text] [Related]
5. [Splenic T-cell and NK-cell lymphomas: a clinicopathologic and immunophenotypic analysis of 9 cases].
Li Z; Liu WP; Tang Y; Jiang LL; Zhang WY; Bi CF; Li GD
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):217-22. PubMed ID: 17877195
[TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic gamma-delta T-cell lymphoma associated with Epstein-Barr virus.
Tsunematsu S; Natsuizaka M; Fujita H; Otsuka N; Terashita K; Sato F; Kobayashi T; Nakai M; Tsukuda Y; Horimoto H; Sho T; Suda G; Nakanishi M; Hashino S; Chuma M; Sakamoto N
Intern Med; 2014; 53(18):2079-82. PubMed ID: 25224191
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic and other gammadelta T-cell lymphomas.
Vega F; Medeiros LJ; Gaulard P
Am J Clin Pathol; 2007 Jun; 127(6):869-80. PubMed ID: 17509984
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases.
Kato S; Asano N; Miyata-Takata T; Takata K; Elsayed AA; Satou A; Takahashi E; Kinoshita T; Nakamura S
Am J Surg Pathol; 2015 Apr; 39(4):462-71. PubMed ID: 25634749
[TBL] [Abstract][Full Text] [Related]
9. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
[TBL] [Abstract][Full Text] [Related]
10. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients.
Wu H; Wasik MA; Przybylski G; Finan J; Haynes B; Moore H; Leonard DG; Montone KT; Naji A; Nowell PC; Kamoun M; Tomaszewski JE; Salhany KE
Am J Clin Pathol; 2000 Apr; 113(4):487-96. PubMed ID: 10761449
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Thai A; Prindiville T
J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
[TBL] [Abstract][Full Text] [Related]
13. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological analysis of three cases of childhood systemic EB virus positive T-cell lymphoproliferative disease].
Wang W; Ti HJ; Nong L; Zhang S; Zhang Y; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):594-8. PubMed ID: 22898854
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
Yabe M; Medeiros LJ; Wang SA; Tang G; Bueso-Ramos CE; Jorgensen JL; Bhagat G; Chen W; Li S; Young KH; Miranda RN
Am J Surg Pathol; 2017 Jan; 41(1):82-93. PubMed ID: 27755009
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
[TBL] [Abstract][Full Text] [Related]
17. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.
Macon WR; Levy NB; Kurtin PJ; Salhany KE; Elkhalifa MY; Casey TT; Craig FE; Vnencak-Jones CL; Gulley ML; Park JP; Cousar JB
Am J Surg Pathol; 2001 Mar; 25(3):285-96. PubMed ID: 11224598
[TBL] [Abstract][Full Text] [Related]
18. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
